目的分析广东省惠州市地区3种常见缺失型β-地中海贫血(简称"地贫")及其合并α-地贫患者的血液学特征。
方法选择2014年6月至2023年12月在惠州市第一妇幼保健院进行血红蛋白电泳检测,血红蛋白F(Hb F)≥5%的1 335例育龄患者作为研究对象。使用血细胞分析仪和全自动毛细管电泳仪检测患者的血液学指标,采用液相芯片和缺口PCR分别检测患者常规地贫基因和3种常见缺失型β-地贫基因,分析缺失型β-地贫患者的血液学特征。本研究已获得惠州市第一妇幼保健院医学伦理委员会的审查[批准号:20231107(B2)]。
结果①共检出384例常见的3种缺失型β-地贫患者,包括184例中国型 Gγ +( Aγδβ) 0、191例东南亚型遗传性持续性胎儿血红蛋白增高症(SEA-HPFH)和9例台湾型,总检出率为28.76%。②排除不符合标准的患者后余372例缺失型β-地贫患者,均表现为小细胞低色素性贫血,Hb F明显升高;除中国型 Gγ +( Aγδβ) 0患者的血红蛋白A 2(Hb A 2)正常或降低之外,其它2种患者的Hb A 2均有不同程度的升高;差异性比较结果显示各组间的Hb A 2和Hb F差异均有统计学意义( P<0.05)。③按基因变异类型将180例中国型 Gγ +( Aγδβ) 0杂合子患者分为3组,包括αα/αα,Chinese Gγ +( Aγδβ) 0/β N组(149例)、-α/αα,Chinese Gγ +( Aγδβ) 0/β N组(14例)和--/αα,Chinese Gγ +( Aγδβ) 0/β N组(17例);将179例SEA-HPFH杂合子患者分为3组,包括αα/αα,SEA-HPFH/β N组(150例)、-α/αα,SEA-HPFH/β N组(12例)和--/αα,SEA-HPFH/β N组(17例);差异性比较结果显示中国型 Gγ +( Aγδβ) 0合并α 0-地贫组的Hb F明显低于合并α +-地贫组以及不合并组(P<0.05),SEA-HPFH合并α 0-地贫组的平均红细胞体积(MCV)、平均红细胞血红蛋白含量(MCH)和Hb F明显低于合并α +-地贫组以及不合并组( P<0.05)。
结论上述研究成果不仅可增强临床医师对缺失型β-地贫及其合并α-地贫的鉴别能力,提高其遗传咨询水平,还能为制定缺失型β-地贫防控方案和开展优生优育提供数据支撑。
ObjectiveTo analyze the hematological characteristics of patients with three common deletional β-thalassemias (β-thal) and concomitant α-thal in Huizhou, Guangdong province.
MethodsA total of 1 335 subjects of childbearing age with hemoglobin F (Hb F) ≥5% at the Huizhou First Maternal and Child Health Care Hospital between June 2014 and December 2023 were enrolled as our study cohort. The hematological parameters were determined by blood cell counters and automatic capillary electrophoresis, while liquid phase chip and gap-PCR were employed for the detection of routine thalassemias and the three common deletional β-thal, respectively. The hematological characteristics of patients with the deletional β-thal were analyzed. This study was reviewed and approved by the Ethics Committee of Huizhou First Maternal and Child Health Care Hospital [Ethics No. 20231107(B2)].
Results① A total of 384 cases of the three common deletional β-thal were identified, including 184 cases of Chinese Gγ + ( Aγδβ) 0, 191 cases of Southeast Asian hereditary persistence of fetal hemoglobin (SEA-HPFH), and nine cases of Taiwanese, for a total detection rate of 28.76%. ② Patients who did not meet the established criteria were excluded from the study, leaving 372 cases. All of which presented with hypochromic microcytic anemia and significantly elevated Hb F. Except for normal or decreasing of Hb A 2 levels in patients with Chinese Gγ + ( Aγδβ) 0, the levels of Hb A 2 in patients with the other two deletional β-thal were increased with different degrees. Differential comparison results showed that significant differences were observed in Hb A 2 and Hb F values among the groups of the three common deletional β-thal heterozygotes ( P<0.05). ③ According to the type of gene variation, 180 patients with Chinese Gγ + ( Aγδβ) 0 heterozygotes were divided into three groups, including αα/αα, Chinese Gγ + ( Aγδβ) 0/β N (149), -α/αα, Chinese Gγ + ( Aγδβ) 0/β N (14), and --/αα, Chinese Gγ + ( Aγδβ) 0/β N (17). Similarly, 179 patients with SEA-HPFH heterozygotes were divided into three groups, including αα/αα, SEA-HPFH/β N (150), -α/αα, SEA-HPFH/β N (12), and --/αα, SEA-HPFH/β N (17). Differential comparison results showed that the Hb F levels of the Chinese Gγ + ( Aγδβ) 0 combined with α 0-thal group were significantly lower than those of the Chinese Gγ + ( Aγδβ) 0 combined with α + -thal group and the control group ( P<0.05). The mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and Hb F values of the SEA-HPFH combined with α 0-thal group were significantly lower than those of the SEA-HPFH combined with α + -thal group and the control group ( P<0.05).
ConclusionThe above research results can not only enhance the ability of clinicians to identify deletional β-thal and concomitant α-thal, improve the level of genetic counseling, but also provide data support for the development of deletional β-thal prevention and control programme and the development of prenatal and postnatal care.
官志扬,陈迪娜,钟泽艳,等. 广东省惠州市地区3种常见缺失型β-地中海贫血及其合并α-地中海贫血患者的血液学特征分析[J]. 中华医学遗传学杂志,2025,42(02):129-136.
DOI:10.3760/cma.j.cn511374-20241013-00570版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
官志扬:实验设计、数据分析、论文撰写、经费支持;陈迪娜:统计分析;钟泽艳:论文修改、经费支持;吴志勇、钟国兴、黄少慧:实验操作、数据采集、随访;陈剑虹:论文审阅、经费支持

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。